These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 15861394

  • 1. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
    Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I.
    J Cell Biochem; 2005 Aug 01; 95(5):918-31. PubMed ID: 15861394
    [Abstract] [Full Text] [Related]

  • 2. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
    Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB.
    J Am Soc Nephrol; 2005 Mar 01; 16(3):667-75. PubMed ID: 15677311
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG.
    Oncogene; 2003 Jul 10; 22(28):4314-32. PubMed ID: 12853969
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
    Peron P, Rahmani M, Zagar Y, Durand-Schneider AM, Lardeux B, Bernuau D.
    J Biol Chem; 2001 Mar 30; 276(13):10524-31. PubMed ID: 11134003
    [Abstract] [Full Text] [Related]

  • 5. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.
    Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A.
    Mol Biol Cell; 2005 Apr 30; 16(4):1987-2002. PubMed ID: 15689496
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 7. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
    Yue J, Mulder KM.
    J Biol Chem; 2000 Oct 06; 275(40):30765-73. PubMed ID: 10843986
    [Abstract] [Full Text] [Related]

  • 8. Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cells.
    Sullivan BP, Kassel KM, Manley S, Baker AK, Luyendyk JP.
    J Pharmacol Exp Ther; 2011 May 06; 337(2):471-8. PubMed ID: 21303922
    [Abstract] [Full Text] [Related]

  • 9. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
    Zavadil J, Cermak L, Soto-Nieves N, Böttinger EP.
    EMBO J; 2004 Mar 10; 23(5):1155-65. PubMed ID: 14976548
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
    Dai C, Yang J, Liu Y.
    J Biol Chem; 2003 Apr 04; 278(14):12537-45. PubMed ID: 12560323
    [Abstract] [Full Text] [Related]

  • 11. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
    Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, Moses HL.
    Breast Cancer Res; 2004 Apr 04; 6(3):R215-31. PubMed ID: 15084245
    [Abstract] [Full Text] [Related]

  • 12. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
    Iglesias M, Frontelo P, Gamallo C, Quintanilla M.
    Oncogene; 2000 Aug 24; 19(36):4134-45. PubMed ID: 10962574
    [Abstract] [Full Text] [Related]

  • 13. PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.
    Freytag J, Wilkins-Port CE, Higgins CE, Higgins SP, Samarakoon R, Higgins PJ.
    J Invest Dermatol; 2010 Sep 24; 130(9):2179-90. PubMed ID: 20428185
    [Abstract] [Full Text] [Related]

  • 14. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.
    Yamamura Y, Hua X, Bergelson S, Lodish HF.
    J Biol Chem; 2000 Nov 17; 275(46):36295-302. PubMed ID: 10942775
    [Abstract] [Full Text] [Related]

  • 15. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D, Shen Q, Chen YQ, Wang MH.
    Oncogene; 2004 Mar 04; 23(9):1668-80. PubMed ID: 15001985
    [Abstract] [Full Text] [Related]

  • 16. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
    Park BJ, Park JI, Byun DS, Park JH, Chi SG.
    Cancer Res; 2000 Jun 01; 60(11):3031-8. PubMed ID: 10850453
    [Abstract] [Full Text] [Related]

  • 17. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H, Yang T, Wang MC, Chen DQ, Yang Y, Zhao YY.
    Phytomedicine; 2018 Mar 15; 42():207-218. PubMed ID: 29655688
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-induced mitoinhibition.
    Han C, Demetris AJ, Liu Y, Shelhamer JH, Wu T.
    J Biol Chem; 2004 Oct 22; 279(43):44344-54. PubMed ID: 15294900
    [Abstract] [Full Text] [Related]

  • 19. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan 22; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 20. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
    Kim HS, Luo L, Pflugfelder SC, Li DQ.
    Invest Ophthalmol Vis Sci; 2005 Mar 22; 46(3):840-8. PubMed ID: 15728539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.